Home › NDC Lookup › Drug shortages › Fluvastatin Sodium Tablet, Extended Release

Fluvastatin Sodium Tablet, Extended Release shortage

Fluvastatin Sodium Tablet, Extended Release is currently listed in shortage by the FDA. The FDA lists 3 affected products. This page was last refreshed from FDA data on Sep 28, 2026.

To Be Discontinued ⚠ Supply risk: High Cardiovascular 3 products 244 days First posted Jan 27, 2026 Updated Jan 27, 2026
Here’s the bottom line

Sandoz is permanently stopping production of its fluvastatin sodium extended-release 80 mg tablets. Other makers still list this same medicine as available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
3
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/1
Affected strengths supplied
244
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 28, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Fluvastatin Sodium Tablet, Extended Release. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
3 NDCs
To be discontinued 3
Affected strengths still supplied
Among manufacturers reporting this shortage
0/1 strengths
No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Fluvastatin Sodium Tablet, Extended Release from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Teva Pharmaceuticals USA, Inc. Lannett Company, Inc.
Plus 6 alternative dosage forms of Fluvastatin Sodium Tablet, Extended Release.
See all other options & details →
Shortage timeline
  1. Jan 27, 2026
    Currently in shortage
    3 of 3 products affected.
  2. Jan 27, 2026
    First reported to the FDA
    3 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Sandoz Inc. 📞 800-525-8747 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31) NDC 66758-0211-31 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01) NDC 00781-8017-01 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31) NDC 00781-8017-31 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Fluvastatin Sodium Tablet, Extended Release — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Fluvastatin Sodium Tablet, Extended Release? options further down this page.

Why is Fluvastatin Sodium Tablet, Extended Release in shortage?

Sandoz Inc. has reported to the FDA that it is permanently stopping the manufacturing of its extended-release fluvastatin sodium 80 mg tablets. This affects two package sizes of the generic version as well as the brand-name Lescol XL, all at the 80 mg strength. No specific reason was shared publicly for why manufacturing is being stopped — Sandoz simply reported that the drug is being discontinued.

It's worth knowing that this report only covers what Sandoz has filed with the FDA. It reflects their decision to stop making these particular products, not necessarily every version of this medicine available on the market.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Fluvastatin Sodium Tablet, Extended Release, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Fluvastatin Sodium Tablet, Extended Release?

Fluvastatin sodium extended-release tablets are currently on the FDA drug-shortage list. I want to walk you through what this means for the strength you take so you can plan calmly.

The affected strength is the 80 mg extended-release tablet. Right now there is no available source reported for this strength, and it is listed as to be discontinued. The reason given is that the manufacturer, Sandoz Inc., is stopping production of this product. Because this is a discontinuation rather than a temporary delay, the supply problem may be lasting — which makes a conversation with your prescriber the right next step.

Please keep in mind this comes from national, manufacturer-reported data and may not match what your local pharmacy actually has on hand.

Here is what I suggest, in order:

  • Do not stop, skip, or change your dose on your own.
  • Ask your pharmacy to check wholesalers and other makers — the same medicine (fluvastatin sodium 80 mg extended-release) is also listed from Teva Pharmaceuticals and Lannett Company, though it may not be in local stock.
  • If your exact product cannot be found, ask your prescriber or pharmacist about options, such as a clinician-chosen alternative.
  • Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles these calls.
See “Where else can I get Fluvastatin Sodium Tablet, Extended Release?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Fluvastatin guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Fluvastatin guide →

Where else can I get Fluvastatin Sodium Tablet, Extended Release?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Fluvastatin Sodium Tablet, Extended Release is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Fluvastatin Sodium FLUVASTATIN SODIUM 80 mg/1 Tablet, Film Coated, Extended Release · Oral Teva Pharmaceuticals USA, Inc. 00093-7446-01
Fluvastatin Sodium FLUVASTATIN SODIUM 80 mg/1 Tablet, Film Coated, Extended Release · Oral Lannett Company, Inc. 00527-2580-32

Alternative dosage forms of Fluvastatin Sodium Tablet, Extended Release

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 5 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Fluvastatin Sodium 80 mgNDC 00093-7446-01 Teva 100 tablets $2.879 save 78% AB Availability likely
Fluvastatin Sodium 80 mgNDC 00527-2580-32 Lannett 30 tablets $2.879 save 78% AB Availability likely
Fluvastatin Sodium Er 80 mgNDC 00781-8017-01 Sandoz 100 tablets $2.879 save 78% AB Availability likely
Fluvastatin Sodium Er 80 mgNDC 00781-8017-31 Sandoz 30 tablets $2.879 AB Availability likely
Lescol XL 80 mgNDC 66758-0211-31 Sandoz 30 tablets $13.064 AB Availability likely

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Fluvastatin Sodium Tablet, Extended Release — that fall in the same broad treatment class (antihyperlipidemic-hmgcoa reductase inhib(statins)) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 046757
GCN 89424
HICL code 008946
Ingredient (HICL) Fluvastatin Sodium
HIC1 code M
Therapeutic class — broad (HIC1) Blood
HIC2 code M4
Therapeutic class — intermediate (HIC2) Affect Blood Lipids/Sugar/Amino Acids
HIC3 code M4D
Therapeutic class — specific (HIC3) Antihyperlipidemic-Hmgcoa Reductase Inhib(Statins)
AHFS code 24:06.08.00
AHFS class Hmg-Coa Reductase Inhibitors
FDB label name LESCOL XL 80 MG TABLET
FDB brand name Lescol Xl
Legend status F — Federal legend — prescription drug or device
GPI-1439400030107530
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Fluvastatin Sodium Tablet, Extended Release shortage FAQs

Is Fluvastatin Sodium Tablet, Extended Release in shortage?
Yes — the FDA currently lists Fluvastatin Sodium Tablet, Extended Release in shortage (status: “To Be Discontinued”, first reported Jan 27, 2026). 3 of 3 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31) (NDC 66758-0211-31); Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01) (NDC 00781-8017-01); Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31) (NDC 00781-8017-31). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Fluvastatin Sodium Tablet, Extended Release be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Fluvastatin Sodium Tablet, Extended Release somewhere?
Other manufacturers (Teva Pharmaceuticals USA, Inc., Lannett Company, Inc.) still market it and have not reported a shortage. 6 alternative dosage forms of Fluvastatin Sodium Tablet, Extended Release are also listed. See “Where else can I get Fluvastatin Sodium Tablet, Extended Release?” above — stock still varies by pharmacy.
What should I do if I take Fluvastatin Sodium Tablet, Extended Release?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Fluvastatin Sodium Tablet, Extended Release shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages